HomeNewsEmtricitabine

Emtricitabine

Jump to

Gilead signs deals with Indian cos for low-cost HIV drug

Gilead Sciences Inc signed deals with three Indian companies to drive sales and reduce manufacturing costs of low-cost generic versions of its HIV drug, Emtricitabine in developing countries.
Gilead ropes in Indian firms to promote cheaper HIV pills

US-based Gilead Sciences has roped in four Indian pharmaceutical companies to develop and market three new generic HIV/AIDS drugs in over 100 countries. The drugs are currently in final stages of clinical development. CNBC-TV18's Appaji Reddem and Ashwin Mohan delve deeper.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Emtricitabine

Gilead signs deals with Indian cos for low-cost HIV drug

Gilead ropes in Indian firms to promote cheaper HIV pills